1. Home
  2. SONO vs ALMR Comparison

SONO vs ALMR Comparison

Compare SONO & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$13.81

Market Cap

1.8B

ML Signal

HOLD

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$26.87

Market Cap

1.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SONO
ALMR
Founded
2002
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
SONO
ALMR
Price
$13.81
$26.87
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$19.67
N/A
AVG Volume (30 Days)
1.7M
243.4K
Earning Date
05-04-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$1,443,276,000.00
N/A
Revenue This Year
$5.04
N/A
Revenue Next Year
$6.53
N/A
P/E Ratio
$27.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.12
$21.58
52 Week High
$19.82
$24.58

Technical Indicators

Market Signals
Indicator
SONO
ALMR
Relative Strength Index (RSI) 38.54 N/A
Support Level $12.67 N/A
Resistance Level $14.76 N/A
Average True Range (ATR) 0.77 0.00
MACD -0.19 0.00
Stochastic Oscillator 5.86 0.00

Price Performance

Historical Comparison
SONO
ALMR

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

Share on Social Networks: